"Colorado Urology, a United Urology Group affiliate, is the region’s premier urology practice with more than 20 urologists and a team of Advanced Practice Providers serving patients at 11 medical offices throughout Boulder, Castle Rock, and the Denver metropolitan area. Colorado Urology provides a comprehensive array of urologic services to patients. The integrated approach to urologic care provides patients with access to experienced specialists, a comprehensive support team of healthcare professionals, innovative diagnostic tools, and highly advanced treatments and therapies."

During the past decade, Colorado Urology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Colorado Urology" #1 sponsor was "Veru Inc." with 3 trials, followed by "Astellas Pharma Inc" with 1 trials sponsored, "Candel Therapeutics, Inc." with 1 trials sponsored, "Dendreon" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Colorado Urology" are "Prostatic Neoplasms" (2 trials), "Advanced Prostate Adenocarcinoma" (1 trials), "Advanced Prostate Cancer" (1 trials), "Androgen Resistant Prostatic Cancer" (1 trials) and "Metastatic Castration Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Colorado Urology" in a lesser frequency.

Most popular intervention types in "Colorado Urology" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "VERU-111" (2 trials), "Aglatimagene besadenovec + valacyclovir" (1 trials), "Enzalutamide, Abiraterone" (1 trials) and "Fesoterodine 8 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colorado Urology" are 6 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Colorado Urology". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Colorado Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Colorado Urology, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".